3rd International Cardiac Sarcoidosis Symposium - 2/23/2024 | Conferences | Continuing Medical Education | The Center for Continuing Medical Education (CCME) at The Ohio State University

February 23^rd, 2024

This conference has already taken place.

Biomedical Research Tower - Columbus, OH

1 Day Conference February 23^rd, 2024

3.75 AMA PRA Category 1 Credit^™ Hours

Cardiology,Cardiovascular Medicine,Clinical Genetics,Critical Care,Emergency Medicine,Family Medicine,Hospital Medicine,Internal Medicine,Medical Genetics and Genomics,Nursing,Pulmonary,Rheumatology

Description

Sarcoidosis is a multidisciplinary disease. Cardiac sarcoidosis is one of the most serious manifestations of systemic sarcoidosis. Due to relatively low prevalence of the disease, understanding about etiology, pathogenesis, clinical manifestation, and management approaches is limited. This symposium involves presentations about diagnosis, management and surveillance of complications related to cardiac sarcoidosis.

REGISTRATION FOR THIS SYMPOSIUM IS NOW CLOSED. FOR INFORMATION ON REGISTRATION PHONE OR EMAIL THE CONTACT LISTED BELOW.

Dates and Times

Start: 2/23/2024 8:00 AM
End: 2/23/2024 12:15 PM

Objectives

At the conclusion of this activity, learners will be able to:

1. Recognize the role of PET and MRI for diagnosis of cardiac sarcoidosis.
2. Review role of serum biomarkers for diagnosis of cardiac sarcoidosis.
3. Identify role of prolonged ambulatory rhythm monitoring for cardiac sarcoidosis.
4. Discuss risk stratification for the need of pacing and defibrillation therapy.
5. Explain the role of immunosuppressants for treatment of cardiac sarcoidosis.
6. Describe management of ventricular arrhythmia in patients with cardiac sarcoidosis.
7. Review surveillance for long-term complications of cardiac sarcoidosis.
8. Identify association of cardiac sarcoidosis and advanced heart failure and pulmonary hypertension.
9. Describe role of multidisciplinary approach for the management of cardiac sarcoidosis.1. Recognize the role of PET and MRI for diagnosis of cardiac sarcoidosis.

Pricing

Tier	Price
Physician, participating in person	$0.00
Physician, participating online	$0.00
Resident/Fellow participating in person	$0.00
Resident/Fellow participating online	$0.00
Nurse/Nurse Practitioner attending in person	$0.00
Nurse/Nurse Practitioner, participating online	$0.00
Allied Medical Professional, participating in person	$0.00
Allied Medical Professional, participating online	$0.00

Speakers

Dr. Muhammad Afzal, MBBS
- Role of Holter, MCT and ILR for arrythmia surveillance and management – Implications of AV block and NSVTs identified during ambulatory monitoring
Dr. David Birnie, MD
- Keynote Lecture: Lessons from CHASM – Rational for the Use of Cardiac PET/CT monitoring
Dr. Elliott Crouser, MD
- How to choose and follow immunosuppressant agents in the management of systemic sarcoidosis
Dr. Ayesha Hasan, MD
- Welcome/Introductions/Opening Remark
Dr. Rami Kahwash, MD
- Management of sarcoidosis associated cardiomyopathy – When and how to use immunosuppressants
Dr. Steven Kalbfleisch, MD
- Risk stratification: Determining which cardiac sarcoidosis patients require device therapy
Dr. Jordana Kron, MD
- Insights from the Cardiac Sarcoid Consortium
Dr. Judith Lin, MD
- Noncardiac and non-pulmonary sarcoidosis, a Rheumatologists’ perspective
Dr. Toshimasa Okabe, MD
- Sustained Ventricular Arrhythmias in Cardiac Sarcoidosis - When to Avoid and When to Consider Ablation Therapy
Dr. Vaiibhav Patel, MD
- Appropriate ordering, preparation and interpretation for Cardiac PET/CT
Dr. Arindam Singha, MD
- When should a non-cardiologist suspect cardiac sarcoid and refer to cardiology?
Dr. Karolina Zareba, MD
- How to use cardiac MRI to differentiate cardiac sarcoid from other cardiomyopathies

Location

Biomedical Research Tower
460 W. 12th Avenue
Room 115
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.